Goldman Sachs’s Forward Pharma A/S American Depositary Shares FWP Stock Holding History

Goldman Sachs’s Portfolio FWP Stock Details FWP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,444	Closed	-$105K	–	6944
2021 Q3	$105K	Buy	+15,444	New	+$136K	﹤0.01%	5899
2016 Q3	–	Sell	-1,468	Closed	-$187K	–	7284
2016 Q2	$187K	Buy	+1,468	New	+$198K	﹤0.01%	5745
2015 Q3	–	Sell	-29,029	Closed	-$7.73M	–	7592
2015 Q2	$7.73M	Sell	29,029 -3,382	-10%	-$809K	﹤0.01%	2551
2015 Q1	$6.42M	Buy	32,411 +1,067	+3%	+$173K	﹤0.01%	2667
2014 Q4	$4.57M	Buy	+31,344	New	+$4.52M	﹤0.01%	3082

Other funds holding FWP

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs's FWP Position: Q4 2021 in Review

Goldman Sachs sold out of Forward Pharma A/S American Depositary Shares (FWP) in Q4 2021, closing a stake of 15,444 shares — an estimated $105K sold.

Goldman Sachs first reported a position in FWP in Q4 2014 and held it in 5 quarters. The position peaked at $7.73M in Q2 2015. 7 funds tracked by Wall St. Rank hold FWP as of Q4 2021.

Goldman Sachs reported no remaining Forward Pharma A/S American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Goldman Sachs sold 15,444 Forward Pharma A/S American Depositary Shares shares in Q4 2021, an estimated $105K.
Goldman Sachs first reported a position in Forward Pharma A/S American Depositary Shares in Q4 2014 and held it in 5 quarters.
Goldman Sachs's Forward Pharma A/S American Depositary Shares position peaked at $7.73M in Q2 2015.
7 funds tracked by Wall St. Rank held Forward Pharma A/S American Depositary Shares as of Q4 2021.

Based on Goldman Sachs's 13F filing for Q4 2021, filed 14 Feb 2022.